ESLA
Price
$1.02
Change
+$0.14 (+15.91%)
Updated
Apr 23 closing price
Capitalization
31.77M
IONS
Price
$29.10
Change
+$0.07 (+0.24%)
Updated
Apr 23 closing price
Capitalization
4.63B
6 days until earnings call
Ad is loading...

ESLA vs IONS

Header iconESLA vs IONS Comparison
Open Charts ESLA vs IONSBanner chart's image
Estrella Immunopharma
Price$1.02
Change+$0.14 (+15.91%)
Volume$673.51K
Capitalization31.77M
Ionis Pharmaceuticals
Price$29.10
Change+$0.07 (+0.24%)
Volume$1.09M
Capitalization4.63B
ESLA vs IONS Comparison Chart
Loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLA vs. IONS commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and IONS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ESLA: $1.02 vs. IONS: $29.10)
Brand notoriety: ESLA and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 609% vs. IONS: 60%
Market capitalization -- ESLA: $31.77M vs. IONS: $4.63B
ESLA [@Biotechnology] is valued at $31.77M. IONS’s [@Biotechnology] market capitalization is $4.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ESLA and IONS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 6 TA indicator(s) are bullish while IONS’s TA Score has 5 bullish TA indicator(s).

  • ESLA’s TA Score: 6 bullish, 4 bearish.
  • IONS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ESLA is a better buy in the short-term than IONS.

Price Growth

ESLA (@Biotechnology) experienced а +21.94% price change this week, while IONS (@Biotechnology) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

ESLA is expected to report earnings on Mar 14, 2023.

IONS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IONS($4.63B) has a higher market cap than ESLA($31.8M). ESLA YTD gains are higher at: -15.008 vs. IONS (-16.762). ESLA has higher annual earnings (EBITDA): -8.82M vs. IONS (-353.72M). IONS has more cash in the bank: 2.3B vs. ESLA (1.8M). IONS has higher revenues than ESLA: IONS (705M) vs ESLA (0).
ESLAIONSESLA / IONS
Capitalization31.8M4.63B1%
EBITDA-8.82M-353.72M2%
Gain YTD-15.008-16.76290%
P/E RatioN/AN/A-
Revenue0705M-
Total Cash1.8M2.3B0%
Total DebtN/A1.42B-
FUNDAMENTALS RATINGS
IONS: Fundamental Ratings
IONS
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESLAIONS
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
43%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
37%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Ad is loading...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMED23.020.43
+1.91%
Fidelity Disruptive Medicine ETF
MLPA49.950.26
+0.52%
Global X MLP ETF
VTN10.000.05
+0.50%
Invesco Trust for Investment Grade New York Municipals
FLDZ26.43N/A
N/A
RiverNorth Patriot ETF
RSPG70.61-0.03
-0.04%
Invesco S&P 500® Equal Weight Energy ETF

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and IONS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+16.10%
IONS - ESLA
26%
Poorly correlated
+0.24%
CARM - ESLA
24%
Poorly correlated
+2.83%
IMUX - ESLA
24%
Poorly correlated
+10.00%
WINT - ESLA
24%
Poorly correlated
+1.83%
CYTOF - ESLA
23%
Poorly correlated
-1.41%
More